ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BICX BioCorRx Inc (QB)

0.75
0.00 (0.00%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 405
Bid Price 0.75
Ask Price 1.45
News -
Day High 0.78

Low
0.672

52 Week Range

High
2.22

Day Low 0.75
Company Name Stock Ticker Symbol Market Type
BioCorRx Inc (QB) BICX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.75 13:22:56
Open Price Low Price High Price Close Price Prev Close
0.78 0.75 0.78 0.75 0.75
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4 405 $ 0.7725 $ 313 - 0.672 - 2.22
Last Trade Time Type Quantity Stock Price Currency
13:22:56 100 $ 0.75 USD

BioCorRx Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.45M 8.50M 1.45M 89k -3.77M -0.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioCorRx (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BICX Message Board. Create One! See More Posts on BICX Message Board See More Message Board Posts

Historical BICX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.021.020.750.75634-0.27-26.47%
1 Month1.1451.500.681.032,340-0.395-34.50%
3 Months0.8151.500.680.97652881,780-0.065-7.98%
6 Months1.581.580.6720.97692452,108-0.83-52.53%
1 Year1.872.220.6721.201,756-1.12-59.89%
3 Years2.868.100.21772.682,106-2.11-73.78%
5 Years5.158.100.1552.602,225-4.40-85.44%

BioCorRx (QB) Description

BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Company's majority owned subsidiary BioCorRx Pharmaceuticals Inc. is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com.

Your Recent History

Delayed Upgrade Clock